Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, April 21, 2021
[ Wed, Apr 21st 2021
] - WOPRAI
[ Wed, Apr 21st 2021
] - WOPRAI
[ Wed, Apr 21st 2021
] - WOPRAI
[ Wed, Apr 21st 2021
] - WOPRAI
[ Wed, Apr 21st 2021
] - WOPRAI
Tue, April 20, 2021
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
Graig Suvannavejh Initiated (TGTX) at Hold and Held Target at $50 on, Apr 20th, 2021
Graig Suvannavejh of Goldman Sachs, Initiated "TG Therapeutics, Inc." (TGTX) at Hold and Held Target at $50 on, Apr 20th, 2021.
Graig has made no other calls on TGTX in the last 4 months.
There are 2 other peers that have a rating on TGTX. Out of the 2 peers that are also analyzing TGTX, 0 agree with Graig's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Graig
- Edward White of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $89 on, Monday, April 19th, 2021
- Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $95 on, Tuesday, February 9th, 2021
